Inhalant use disorder is rare in addiction-treatment populations but devastating when present. The neurological impact of inhalants — solvents, aerosols, nitrites, gases — is severe and unique among substance use disorders. RECO Intensive treats inhalant use disorder with the neurological seriousness it requires.
The clinical picture of inhalant use disorder
- Acute neurological effects — slurred speech, motor incoordination, cognitive impairment during intoxication
- Lasting neurological damage — white matter changes, cognitive deficits, sometimes severe
- "Sudden Sniffing Death Syndrome" — cardiac arrhythmias from inhalant use can cause sudden death
- Multi-organ damage — liver, kidney, lung — from chronic use
- Mood and psychotic features in some chronic users
- Significant medical comorbidity — often underdiagnosed before treatment
How RECO treats inhalant use disorder
Comprehensive neurological assessment
Within the first weeks, our medical team conducts a full neurological workup — cognitive testing, neurological exam, brain imaging when indicated. Many inhalant clients arrive with measurable cognitive impairment that needs accurate assessment to inform the treatment plan.
Medical stabilization and organ-system care
Our medical detox supports the acute physical recovery phase with attention to cardiovascular monitoring, electrolyte balance, and any organ-system damage detected at intake. Coordination with outside specialists for severe organ damage when needed.
Adapted therapeutic approach
Cognitive impairment can complicate traditional talk therapy. Our clinical team adapts — slower pacing, more concrete language, additional repetition, more reliance on experiential and somatic modalities like equine therapy, HRV training, and expressive arts.
Long-arc cognitive recovery
Some inhalant-related cognitive deficits improve with sustained sobriety; some are permanent. Our team works with clients realistically about the recovery trajectory while delivering the work that maximizes brain recovery potential — nutrition, sleep, exercise, brain-supportive supplementation.
Who this track serves
Clients with current or recent inhalant use. Clients with prior inhalant use whose neurological consequences are still active. Adolescents and young adults whose inhalant use has produced cognitive impact. Polysubstance clients where inhalants are part of the picture. Anyone whose inhalant use has reached clinical significance.
What inhalant recovery looks like at RECO
Detox phase is typically brief medically but the post-acute neurological recovery phase is extended. Residential care provides the structure and support that cognitive impairment makes essential. Aftercare planning takes the cognitive picture into account — concrete plans, structured support, ongoing cognitive rehabilitation where appropriate.
Why RECO's approach is different
Many programs decline inhalant clients because of the clinical complexity. We accept them and treat them with appropriate neurological depth — and the integration of medical, cognitive, and therapeutic care is what allows recovery to hold even with the neurological challenges inhalants produce.
